Jeffrey M. Leiden
2015 - Vertex Pharmaceuticals
|Non-Equity Incentive Plan||$3,463,200|
Leiden received $16.3M in option awards, accounting for 58% of the total pay in 2015.
Leiden also received $3.5M in non-equity incentive plan, $1.3M in salary, $7M in stock awards and $13.1K in other compensation.
In 2015, Jeffrey M. Leiden's compensation ranked 43rd out of 13,638 executives tracked by ExecPay. In other words, Leiden earned more than 99.7% of executives.
Chemicals And Allied Products
We found four more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2015.